Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Novick

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2009
Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?Catherine Reed, Diego Novick, Ana Gonzalez-Pinto, et al.
Value in Health Regional Issues|April 22, 2023
Treatment Patterns and Health Resource Utilization in Patients With HR+/ HER2- Locally Advanced or Metastatic Breast Cancer in a Real-World Setting in TaiwanDiego Novick, Narayan Rajan, Alice Wei, et al.
Journal of Drug Assessment|August 15, 2022
Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in KoreaDiego Novick, Sae Young Lee, Dong Hyun Koo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 9, 2009
Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) studyDiego Novick, Josep Maria Haro, Elena Perrin, et al.
International Clinical Psychopharmacology|June 12, 2008
Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes studyDiego Novick, Josep Maria Haro, David Suarez, et al.
The Journal of Headache and Pain|July 17, 2023
Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) studyJulio Pascual, Tommaso Panni, Grazia Dell'Agnello, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 15, 2012
Empirically driven definitions of "good," "moderate," and "poor" levels of functioning in the treatment of schizophreniaHaya Ascher-Svanum, Diego Novick, Josep Maria Haro, et al.
Neuropsychiatric Disease and Treatment|November 25, 2016
Sex differences in the course of schizophrenia across diverse regions of the worldDiego Novick, William Montgomery, Tamas Treuer, et al.
Pharmacopsychiatry|February 17, 2017
Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative SymptomsDiego Novick, William Montgomery, Tamas Treuer, et al.
Journal of Medical Economics|February 22, 2013
Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetineZhanglin Cui, Douglas E Faries, Wei Shen, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 7, 2009
Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?Catherine Reed, Diego Novick, Ana Gonzalez-Pinto, et al.
Value in Health Regional Issues|April 22, 2023
Treatment Patterns and Health Resource Utilization in Patients With HR+/ HER2- Locally Advanced or Metastatic Breast Cancer in a Real-World Setting in TaiwanDiego Novick, Narayan Rajan, Alice Wei, et al.
Journal of Drug Assessment|August 15, 2022
Real world evidence study on treatment patterns and health resource utilization in patients with HR+/HER2- locally advanced or metastatic breast cancer in KoreaDiego Novick, Sae Young Lee, Dong Hyun Koo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 9, 2009
Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) studyDiego Novick, Josep Maria Haro, Elena Perrin, et al.
International Clinical Psychopharmacology|June 12, 2008
Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes studyDiego Novick, Josep Maria Haro, David Suarez, et al.
The Journal of Headache and Pain|July 17, 2023
Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) studyJulio Pascual, Tommaso Panni, Grazia Dell'Agnello, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 15, 2012
Empirically driven definitions of "good," "moderate," and "poor" levels of functioning in the treatment of schizophreniaHaya Ascher-Svanum, Diego Novick, Josep Maria Haro, et al.
Neuropsychiatric Disease and Treatment|November 25, 2016
Sex differences in the course of schizophrenia across diverse regions of the worldDiego Novick, William Montgomery, Tamas Treuer, et al.
Pharmacopsychiatry|February 17, 2017
Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative SymptomsDiego Novick, William Montgomery, Tamas Treuer, et al.
Journal of Medical Economics|February 22, 2013
Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetineZhanglin Cui, Douglas E Faries, Wei Shen, et al.
Pageof 10